Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts

Author(s):
Pagan, L. (0000-0002-2064-7501); Yfanti, C.; Rijneveld, R.; Todd, M.; Jongste, P.; Feijen, J.J.; Klaassen, E.S.; Bavinck, J.N.B.; Struijk, L.; Koning, M.N.C. de; Prestegarden, L.; Niemeyer-van der Kolk, T.; Poelgeest, M.I.E. van; Rissmann, R.
Published
2021
Publication type
Article / Letter to editor
Date issued
2021-12-23
Language
English
Is part of
Journal of the European Academy of Dermatology and Venereology (2021), Vol. 36, no. 10, p. e773-e775
hdl
1887/3769088
doi
10.1111/jdv.18291